Publications by authors named "Hyo-Rak Lee"

Claim this Profile
C
Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study.
Yoon Jung Jang, Joonseog Kong, Heyjin Kim, Chulkue Pak, Im Il Na, Hyo-Rak Lee

Clin Med Insights Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors.
Yoon Jung Jang, Heyjin Kim, Sang-Young Ryu, Moon-Hong Kim, Beob-Jong Kim, Hyo-Rak Lee

Transl Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study.
Yoon Jung Jang, Hong Kyu Jeong, Chang-Bae Kong, Won Seok Song, Wan Hyeong Cho, Hyo-Rak Lee

Oncol Lett· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy with I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Seung-Sook Lee, Mark Hong Lee, Hyo-Rak Lee

Asia Pac J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Seung-Sook Lee, Hyo-Rak Lee

Clin Med Insights Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosome aberration dynamics in breast cancer patients treated with radiotherapy: Implications for radiation biodosimetry.
Younghyun Lee, Jin-Kyu Kang, Yang Hee Lee, Hyo Jin Yoon, Su San Yang, Hyo Rak Lee

Mutat Res Genet Toxicol Environ Mutagen· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors.
Yoon Jung Jang, Seo Yun Kim, Hong Kyu Jung, Hye-Ryoun Kim, Cheol Hyeon Kim, Hyo-Rak Lee

Transl Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial).
Keun-Wook Lee, Ik-Joo Chung, Min-Hee Ryu, Young Iee Park, Byung-Ho Nam, Kyung Hee Lee, Hyo Rak Lee

Gastric Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study.
Jung Hoon Kim, Sang-Cheol Lee, Sung Yong Oh, Seo-Young Song, Namsu Lee, Soonil Lee, Hyo Rak Lee, Kyu Taek Lee, Hyun Woo Lee

Cancer Commun (Lond)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
In Gyu Hwang, Jun Ho Ji, Jung Hun Kang, Hyo Rak Lee, Hui-Young Lee, Su Jin Lee, Jeeyun Lee

J Geriatr Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.
Dong-Yeop Shin, Areumnuri Kim, Byung Hyun Byun, Hansol Moon, Soyeun Kim, Hyo-Rak Lee, Seung Sook Lee

Ann Hematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site.
Dong-Yeop Shin, Yoon Hee Choi, Hyo-Rak Lee, Im Il Na, Young Jin Yuh

Cancer Chemother Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation.
Dong-Yeop Shin, Hyo-Rak Lee, Hye Jin Kang, Im Il Na, Yoon Hwan Chang

Blood Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer.
In Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, Myung Hwan Rho, Suee Lee, Hyo Rak Lee

Cancer Chemother Pharmacol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study.
Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Sang-Cheol Lee, Hyo Rak Lee

Eur J Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic biodosimetry for Fukushima travelers after the nuclear power plant accident: no evidence of enhanced yield of dicentrics.
Jin Kyung Lee, Eun-Ae Han, Seung-Sook Lee, Wi-Ho Ha, Joan Francesc Barquinero, Hyo Rak Lee

J Radiat Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of primary bone lymphoma in Korea.
So Yeon Kim, Dong-Yeop Shin, Seung-Sook Lee, Cheolwon Suh, Jae-Yong Kwak, Jae Hoon Lee, Soon Il Lee, Ye Rim Lee, Min Jae Lee, Hyo-Rak Lee

Korean J Hematol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer.
Gun Hi Kang, Gwang Sil Kim, Hyo Rak Lee, Young Jin Yuh, Sung Rok Kim

Cancer Res Treat· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and carboplatin combination chemotherapy for elderly patients with advanced Non-Small Cell Lung Cancer: a feasibility study.
Young Jin Yuh, Hyo Rak Lee, Sung Rok Kim

Cancer Res Treat· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
Jeeyun Lee, Young-Hyuck Im, Eun Yoon Cho, Yong Sang Hong, Hyo Rak Lee

Cancer Chemother Pharmacol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma.
Byeong-Bae Park, Joon Oh Park, Hyo Rak Lee, Jeeyun Lee, Dong Wook Choi, Jong Kyun Lee, Kyu Taek Lee

Cancer Chemother Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postremission therapy for acute myeloid leukemia in the first remission.
Seung Tai Kim, Chul Won Jung, Jeeyun Lee, Jung Mi Kwon, Sung Young Oh, Hyo Rak Lee

Leuk Lymphoma· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
Sung Yong Oh, Baek-Yeol Ryoo, Won Seog Kim, Kihyun Kim, Jeeyun Lee, Hyo Rak Lee, Seung-Sook Lee

Ann Hematol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen.
Se Hoon Park, Won Ki Kang, Hyo Rak Lee, Jinny Park, Kyung-Eun Lee, Se Hoon Lee, Mark H Lee

Am J Clin Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.
Kihyun Kim, Eunmi Nam, Nam Soo Lee, Hye Ran Lee, Jee Yun Lee, Hyo Rak Lee, Mark H Lee, Woo Yong Lee

Am J Clin Oncol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis